FT DIGITAL HEALTH SUMMIT USA

Transcription

1 F DIGIAL HEALH SUMMI USA Accelerating Patient Empowerment in Health and Wellness October 27, 2016 Convene Park Avenue NEW YORK SPEAKERS INCLUDE: Amrit Ray Chief Medical Officer, Janssen Pharmaceuticals David Schlanger CEO, WebMD Esther Dyson Chairman, EDventure and Executive Founder, Way o Wellville Bakul Patel Associate Director for Digital Health, US Food and Drug Administration (FDA) With the support of Lead Sponsor

2 F DIGIAL HEALH SUMMI USA With the healthcare industry continuing to experience an explosion of innovative technologies, regulatory bodies and associations are going to have a greater role to play in the speed in which digital health is truly realized. Combined with patient representatives having greater input into the formats and delivery of healthcare, the industry is still at a crucial turning point as wider market acceptance and international opportunities for digital devices hang in the balance. Following the success of the inaugural F Digital Health Summit USA, the event returns this year to once again target the most pressing challenges and opportunities within the industry. Expanding the expert speaker roster to include greater patient representation, the agenda will look at how the wider consumer market is accepting digital health technologies as well as their potential in driving more proactive healthcare. WHY AEND? Assess how health technologies can give greater control to patients via more proactive health and wellness management ruly identify the ways in which digital health can be fully adopted and not just hyped about Gain insight into how far the funding boom for digital health is willing to go before wide-scale commercial viability is achieved Validate the threat of cyber attacks in healthcare as more and more technologies and data systems are incorporated into the industry Meet and hear from leading pharmaceutical executives on how their stance on digital health is changing in light of boundaries lines in healthcare becoming more blurred WHO AENDS? he F Digital Health Summit will be attended by: CEOs, Chief Medical Officers, CFOs, COs, CIOs, Heads of Healthcare, Directors of Innovation, Managing Directors, Healthcare Investment, echnology Directors, Heads of Life Sciences, Heads of Disruptive Innovation, Heads of R&D.

3 F DIGIAL HEALH SUMMI USA CONFERENCE AGENDA hursday 27 October :00am Registration and breakfast 9:00am Welcome remarks from the chair David Crow, Senior US Business Correspondent, Financial imes 9:05am Opening keynote and conversation How can we achieve a digitized healthcare system that allows for industry-wide collaboration between all stakeholders and greater empowerment of patients? David Schlanger, CEO, WebMD 9:30am Panel: Adopting digital health what needs to be done? he potential of digital health is undeniable; proactive healthcare, reduced primary care costs, patient empowerment and consumer well-being. However, making sure healthcare s digital transformation is widely available and cost effective for all stakeholders still poses some major challenges. Interoperability for one is an obstacle that threatens the development of digital healthcare as traditionally its systems are unable to integrate with new technologies. How can this industry-wide problem be overcome? A leading panel discusses how an industry traditionally known for being slow at transformation can make the leap and adapt to the new digital era.. Rob Rebak, CEO, Abilo Edward Scal, Chief Business Officer, Fitbit 10:15am Dual interview: he rise of the digital doctor and its role in primary care he landscape for doctors and patients is changing. Where once patients had very limited access to condition and treatment information, connected and mobile technology now allow patients to be proactive and take greater control of their diagnosis, treatment and aftercare. On the flip side doctors also have access to a much wider range of data, data that is available at the click of a button and which allows doctors to become more efficient with their time and treatment. Dr Steven Corwin, President and CEO, NewYork-Presbyterian Hospital 10:45am Networking break

4 11:15am Panel: Creating efficient digital pathways for patients and their data Healthcare systems such as Accountable Care Organizations, have the power to be incredibly strong and resourceful research engines. heir assets doctors, clinics, labs and hospitals to name a few acquire vast amounts of data on a daily basis. Harnessed in conjunction with each other, these data sets could be a driving force behind more sustainable and cost-effective primary care. Using data sets in isolation though will not solve the problem so how can digital technologies be used in such a way to ensure every patient is a research Deborah Kilpatrick, CEO, Evidation Health Jonathan Linkous, CEO, American elemedicine Association alya Miron-Shatz, CEO and Founder, CureMyWay MODERAOR Brett Davis, General Manager, ConvergeHEALH, Deloitte 11:55am In conversation with the F: Power and privacy the importance of cyber security in digital health Bakul Patel, Associate Director for Digital Health, US Food and Drug Administration discusses the latest developments and threats surrounding patient protection in the healthcare industry and how all stakeholders will need to address cyber security in order to protect medical data 12:10pm Panel: Financing digital health how long can the funding boom last? he digital health industry is still relatively new and in the past four years has seen its venture funding levels dramatically increase, almost fourfold over the period. However, whilst the R&D and potential behind digital health is still hyped about, companies are desperately trying to prove they can make money. Recent examples of companies who have had IPOs have seen mixed results and in some cases have seen their share price significantly drop. A panel of healthcare finance experts analyse the future of digital health funding. Is there a sense of finance reality coming back into the market? Are all digital health companies going to experience a restriction on funds, not just ones that are being publicly listed? Assessing the balance of healthcare investors and technology investors in the industry and which should digital health companies look to attract? Esther Dyson, Executive Founder, Way to Wellville and Chairman, EDventure Jody Holtzman, Senior Vice President, Enterprise Strategy and Innovation, AARP Dave Schulte, Managing Director, McKesson Ventures

5 12:50pm Keynote fireside chat Dr Amrit Ray, Chief Medical Officer, Janssen Pharmaceuticals 1:10pm Lunch 2:15pm Panel: Creating simple and effective reimbursement models for digital health A lack of clearly defined reimbursement models currently threatens the integration of digital technologies into healthcare. Specifically mhealth health-related apps and wearable devices which are growing rapidly in demand are difficult to monetize because the reimbursement methods are so blurred. Whilst this delays the development of digital health being adopted across the industry, it also prevents applications and technologies being used for higher clinical purposes instead of day-to-day wellness activities. How can the industry get reimbursed effectively? What forms of evidence should be used in order to justify digital health reimbursement and how can the healthcare industry upgrade its reimbursement models so that digital health can take the next step towards mainstream use? 3:00pm Spotlight session: he start-up disruptors Small scale disruptors have dominated the backbone of digital health innovation since the industry s inception. hey range significantly in terms of application, purpose and delivery however they have all played a vital role in attempting to bring disruption back to the patient through proactive healthcare technologies. hree 15-minutes interviews, each commencing with a 5-minute opening presentation will showcase the latest innovations within the industry. 3:00pm - Dr Jean Nehme, CEO, ouch Surgery 3:15pm - Andy Page, President, 23andMe 3:30pm - Omri Shor, CEO and Co-founder, Medisafe MODERAOR David Martin, Global Strategy Service Line Leader, Deloitte 3:45pm Pre-panel keynote - he pharma perspective Professor Yitzhak Peterburg, Chairman of the Board of Directors, eva Pharmaceutical Industries

6 3:55pm Panel: he pharma perspective how much value is the industry going to have to seed? With governments trying to cut healthcare costs around the world, finding new products, drugs and devices is getting harder. With the rise of digital health and specifically an enormous increase in the amount of available data sets pharma companies are set to potentially lose more control over their future business. However sharing more data and collaborating more with the biotech and tech industries could allow them to become more outcome focused rather than asset controlling. An industry leading panel discusses how a future pharmaceutical company needs to act in order to maintain their foothold in an evolving healthcare industry. Professor Yitzhak Peterburg, Chairman of the Board of Directors, eva Pharmaceutical Industries Judy Sewards, Vice President, Head of Digital Strategy & Data Innovation, Pfizer Dr Susan Shiff, Senior Vice President, Center for Observational and Real-World Evidence, Merck 4:30pm In conversation with the patient he F interviews Michael Seres, EPatient-in-Residence, Stanford Medicine X and Founder, 11Health about his experiences and involvement in the rise of digital health from a patient s perspective 4:50pm Closing keynote and conversation Better empowering patients through unified digital healthcare Ryan Olohan, Head of Healthcare, Google 5:20pm Chair s closing remarks David Crow, Senior US Business Correspondent, Financial imes For the latest program and speaker updates, visit: live.ft.com/digitalhealthus *Program correct as of August 25, 2016

7 F DIGIAL HEALH SUMMI USA SUMMI REGISRAION FEES Conference Fees Conference Fees Standard rate $1,095 Non-Profit rate $595 Discounts available for group bookings and for F and F.com subscribers. Please contact Chandni Saberwal at chandni.saberwal@ft.com or for more information regarding registration. HOW O REGISER: live.ft.com/digitalhealthus VENUE AND ACCOMMODAION Convene 237 Park Avenue 237 Park Avenue New York, NY W +1 (646) SPONSORSHIP OPPORUNIIES im Powell SPEAKING OPPORUNIIES Charlie Hayward REGISRAION INQUIRIES Chandni Saberwal (0) E tim.powell@ft.com E charlie.hayward@ft.com E #FDigHealth facebook.com/financialimes on.ft.com/linkedin